Insomnia Market Size, Share, Regional Outlook, Competitive Strategies And Forecasts,Pipeline 2015

1. Hexa Reports Market Research Reports and Insightful Company Profiles Global Insomnia Industry 2015 Market Share, Size, Industry Profile, Market Prize, Forecast and Overview Global Markets Direct's, 'Insomnia - Pipeline Review, H1 2015', provides an overview of the Insomnia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Insomnia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Insomnia and special features on late-stage and discontinued projects. Browse Detail Report With TOC @http://www.hexareports.com/report/insomnia-pipeline-review- h1-2015/details Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

2. Hexa Reports Market Research Reports and Insightful Company Profiles The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides a snapshot of the global therapeutic landscape of Insomnia The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Insomnia and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Insomnia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre- registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Insomnia pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Insomnia Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Insomnia pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope

3. Hexa Reports Market Research Reports and Insightful Company Profiles Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Request A Sample copy of This Report @ http://www.hexareports.com/sample/47459 Table Of Content Table of Contents 2 List of Tables 6 List of Figures 7 Introduction 8 Global Markets Direct Report Coverage 8 Insomnia Overview 9 Therapeutics Development 10 Pipeline Products for Insomnia - Overview 10 Pipeline Products for Insomnia - Comparative Analysis 11 Insomnia - Therapeutics under Development by Companies 12 Insomnia - Therapeutics under Investigation by Universities/Institutes 14 Insomnia - Pipeline Products Glance 15 Late Stage Products 15 Clinical Stage Products 16 Early Stage Products 17 Insomnia - Products under Development by Companies 18 Insomnia - Products under Investigation by Universities/Institutes 20 Insomnia - Companies Involved in Therapeutics Development 21 Actelion Ltd 21 Alexza Pharmaceuticals, Inc. 22 Eisai Co., Ltd. 23 Evotec AG 24 Grupo Ferrer Internacional, S.A. 25 Heptares Therapeutics Ltd. 26 Intec Pharma ltd. 27 Intra-Cellular Therapies, Inc. 28 Johnson & Johnson 29 Merck & Co., Inc. 30 Minerva Neurosciences, Inc. 31 Neurim Pharmaceuticals Ltd 32 Novartis AG 33 Reviva Pharmaceuticals Inc. 34 Rottapharm SpA 35 Shionogi & Co., Ltd. 36 Somnus Therapeutics, Inc. 37

4. Hexa Reports Market Research Reports and Insightful Company Profiles Takeda Pharmaceutical Company Limited 38 Insomnia - Therapeutics Assessment 39 Assessment by Monotherapy Products 39 Assessment by Target 40 Assessment by Mechanism of Action 42 Assessment by Route of Administration 44 Assessment by Molecule Type 46 Drug Profiles 47 ACT-462206 - Drug Profile 47 Product Description 47 Mechanism of Action 47 R&D Progress 47 CR-5542 Series - Drug Profile 48 Product Description 48 Mechanism of Action 48 R&D Progress 48 Drugs to Inhibit Angiotensin II Receptor Type 1 for Insomnia - Drug Profile 49 Product Description 49 Browse Full Report @ http://www.hexareports.com/report/insomnia-pipeline-review-h1- 2015/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Our Blogs: http://hexareports.blogspot.in